Skip to content
★ Sign in to follow
RI

RayzeBio, Inc. Stock: price and insider trades · United States

No insider purchase over the last 90 days. The latest, by VIKING GLOBAL INVESTORS LP, was filed 21 Sept 2023.

Insider Decl.
30
Thresholds
n/a
Buy Volume
€27M
3 ops. · all time
Sell Volume
n/a
n/a

RayzeBio, Inc.: what insiders have been doing

RayzeBio, Inc. is a listed company. Its insiders report their share dealings to SEC (Form 4). No insider at RayzeBio, Inc. has published a filing in the past twelve months. The most recent one dates from 28 February 2024.

The full history, which starts in 2023, counts 3 purchases against no sales.

Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Financial data

as of FY 2023

FY ended September 2023 · cache

Last declaration on 28 February 2024

T+90 is the date 90 days after the filing, the exit horizon used to measure each purchase.

Declarations30 total
  • ●
    Related company / holdingExecutives
    0SEC
    1,743,556 sharesCommon StockSEC:0000905148-24-000813:1
  • ●
    Related company / holdingExecutives
    0SEC
    1,743,556 sharesCommon StockSEC:0000905148-24-000814:1
  • ●
    Related company / holdingExecutives
    0SEC
    4,899,144 sharesCommon StockSEC:0000905148-24-000814:0
  • ●
    Related company / holdingExecutives
    0SEC
    4,899,144 sharesCommon StockSEC:0000905148-24-000813:0
  • ●
    DirectorExecutives
    23M USD19SEC
    367,446 shares@ US$62.50100.0% of flowCommon StockSEC:0001415889-24-005525:0
  • ●
    DirectorExecutives
    76M USD19SEC
    1,209,764 shares@ US$62.50100.0% of flowCommon StockSEC:0001415889-24-005511:0
  • ●
    CHIEF FINANCIAL OFFICERExecutives
    5M USD27SEC
    78,433 shares@ US$62.50100.0% of flowCommon StockSEC:0001415889-24-005502:0
  • ●
    CHIEF MEDICAL OFFICERExecutives
    20M USD19SEC
    323,455 shares@ US$62.5099.5% of flowCommon StockSEC:0001415889-24-005507:0
  • ●
    PRESIDENT AND CHIEF EXECUTIVEExecutives
    101M USD30SEC
    1,622,968 shares@ US$62.50100.0% of flowCommon StockSEC:0001415889-24-005500:0
  • ◇
    CHIEF MEDICAL OFFICERExecutives
    100,035 USD11SEC
    30,875 shares@ US$3.240.5% of flowCommon StockSEC:0001415889-24-002852:0
  • ▲
    Related company / holdingExecutives
    17M USD24SEC
    930,556 shares@ US$18.0067.0% of flowCommon StockSEC:0000905148-23-000959:3
    Canonical exit: 18 Dec 2023 (T+90)
  • ▲
    Related company / holdingExecutives
    8M USD20SEC
    458,333 shares@ US$18.0033.0% of flowCommon StockSEC:0000905148-23-000959:5
    Canonical exit: 18 Dec 2023 (T+90)
  • ●
    Related company / holdingExecutives
    0SEC
    1,123,862 sharesCommon StockSEC:0000905148-23-000957:1
  • ●
    Related company / holdingExecutives
    0SEC
    247,343 sharesCommon StockSEC:0000905148-23-000957:2
  • ●
    Related company / holdingExecutives
    0SEC
    494,687 sharesCommon StockSEC:0000905148-23-000959:1
  • ●
    Related company / holdingExecutives
    0SEC
    2,609,392 sharesCommon StockSEC:0000905148-23-000959:2
  • ●
    Related company / holdingExecutives
    0SEC
    1,285,223 sharesCommon StockSEC:0000905148-23-000959:4
  • ●
    Related company / holdingExecutives
    0SEC
    494,687 sharesCommon StockSEC:0000905148-23-000958:1
  • ●
    Related company / holdingExecutives
    0SEC
    2,609,392 sharesCommon StockSEC:0000905148-23-000958:2
  • ●
    Related company / holdingExecutives
    0SEC
    1,285,223 sharesCommon StockSEC:0000905148-23-000958:4
  • ●
    Related company / holdingExecutives
    0SEC
    494,687 sharesCommon StockSEC:0001104659-23-102920:1
  • ●
    Related company / holdingExecutives
    0SEC
    498,510 sharesCommon StockSEC:0001104659-23-102920:2
  • ●
    DirectorExecutives
    0SEC
    973,653 sharesCommon StockSEC:0001209191-23-050305:1
  • ▲
    DirectorExecutives
    4M USD24SEC
    236,111 shares@ US$18.005.4% of flowCommon StockSEC:0001209191-23-050305:2
    Canonical exit: 18 Dec 2023 (T+90)
  • ●
    Related company / holdingExecutives
    0SEC
    864,509 sharesCommon StockSEC:0000905148-23-000958:0

25 of 30 declarations

About RayzeBio, Inc.

RayzeBio, Inc. is a company focused on developing innovative therapies for cancer treatment. It is listed on the XNAS market.

Written on 25 June 2026 from the filings and market data available that day. Live figures are in the blocks above.

The weekly insider digest, free

One email on Fridays: the insider clusters and single-name signals worth reading. Unsubscribe in one click.